tilorone has been researched along with Alveolitis, Fibrosing in 1 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vartiainen, V | 1 |
Raula, J | 1 |
Bimbo, LM | 1 |
Viinamäki, J | 1 |
Backman, JT | 1 |
Ugur, N | 1 |
Kauppinen, E | 1 |
Sutinen, E | 1 |
Joensuu, E | 1 |
Koli, K | 1 |
Myllärniemi, M | 1 |
1 other study available for tilorone and Alveolitis, Fibrosing
Article | Year |
---|---|
Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice.
Topics: Administration, Inhalation; Animals; Cell Line; Dry Powder Inhalers; Humans; Leucine; Lung; Male; Mi | 2018 |